Brian Mueller Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Brian Mueller is EVP, Chief Financial Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 99,781 shares of BMRN, which is worth approximately $5.67 Million. The most recent transaction as insider was on Jul 08, 2022, when has been sold 7,337 shares (Common Stock) at a price of $89.5 per share, resulting in proceeds of $656,662. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.8K

1.83% 3M change

38.28% 12M change

Total Value Held $5.67 Million

Brian Mueller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 08 2022	SELL Open market or private sale	$656,662 $89.5 p/Share	7,337 Reduced 19.28%	30,726 Common Stock
Jun 29 2022	SELL Payment of exercise price or tax liability	$48,338 $83.92 p/Share	576 Reduced 1.49%	38,063 Common Stock
May 04 2022	SELL Open market or private sale	$997,100 $84.5 p/Share	11,800 Reduced 23.39%	38,639 Common Stock
May 04 2022	BUY Exercise of conversion of derivative security	$442,028 $37.46 p/Share	11,800 Added 19.6%	48,401 Common Stock
Apr 29 2022	BUY Grant, award, or other acquisition	$21,219 $62.41 p/Share	340 Added 0.87%	38,639 Common Stock
Mar 16 2022	SELL Payment of exercise price or tax liability	$46,979 $80.72 p/Share	582 Reduced 1.5%	38,299 Common Stock
Mar 15 2022	SELL Payment of exercise price or tax liability	$146,208 $78.27 p/Share	1,868 Reduced 4.58%	38,881 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	11,040 Added 21.32%	40,749 Common Stock
Feb 03 2022	SELL Payment of exercise price or tax liability	$94,089 $87.77 p/Share	1,072 Reduced 3.48%	29,709 Common Stock
Jun 29 2021	SELL Payment of exercise price or tax liability	$48,073 $83.46 p/Share	576 Reduced 1.84%	30,781 Common Stock
May 07 2021	SELL Open market or private sale	$533,366 $79.5 p/Share	6,709 Reduced 17.62%	31,357 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$189,395 $28.23 p/Share	6,709 Added 14.98%	38,066 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	$21,282 $62.41 p/Share	341 Added 1.08%	31,357 Common Stock
Apr 01 2021	SELL Open market or private sale	$434,300 $76.3 p/Share	5,692 Reduced 15.51%	31,016 Common Stock
Mar 22 2021	SELL Payment of exercise price or tax liability	$40,516 $78.52 p/Share	516 Reduced 1.39%	36,708 Common Stock
Mar 16 2021	SELL Payment of exercise price or tax liability	$44,936 $77.21 p/Share	582 Reduced 1.54%	37,224 Common Stock
Mar 15 2021	SELL Payment of exercise price or tax liability	$77,920 $78.39 p/Share	994 Reduced 2.56%	37,806 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	10,110 Added 20.67%	38,800 Common Stock
Feb 03 2021	SELL Payment of exercise price or tax liability	$88,700 $82.82 p/Share	1,071 Reduced 3.6%	28,673 Common Stock

Brian Mueller

EVP, Chief Financial Officer

Novato, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Value

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN

Account